GR3007389T3 - - Google Patents

Info

Publication number
GR3007389T3
GR3007389T3 GR920402603T GR920402603T GR3007389T3 GR 3007389 T3 GR3007389 T3 GR 3007389T3 GR 920402603 T GR920402603 T GR 920402603T GR 920402603 T GR920402603 T GR 920402603T GR 3007389 T3 GR3007389 T3 GR 3007389T3
Authority
GR
Greece
Prior art keywords
formula
amino acid
acid residue
acids
hydroxamic acids
Prior art date
Application number
GR920402603T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3007389T3 publication Critical patent/GR3007389T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR920402603T 1986-01-21 1993-03-18 GR3007389T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868601368A GB8601368D0 (en) 1986-01-21 1986-01-21 Hydroxamic acids

Publications (1)

Publication Number Publication Date
GR3007389T3 true GR3007389T3 (el) 1993-07-30

Family

ID=10591684

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402603T GR3007389T3 (el) 1986-01-21 1993-03-18

Country Status (7)

Country Link
EP (1) EP0231081B1 (el)
JP (1) JP2532859B2 (el)
AT (1) ATE87005T1 (el)
DE (1) DE3784743T2 (el)
ES (1) ES2053525T3 (el)
GB (1) GB8601368D0 (el)
GR (1) GR3007389T3 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2045621A1 (en) * 1989-11-24 1991-05-25 Akira Okuyama Physiologically active substance be-16627
GB9211707D0 (en) * 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
GB9211706D0 (en) * 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
GB9213473D0 (en) * 1992-06-25 1992-08-12 Hoffmann La Roche Hydroxamic acid derivatives
AU666727B2 (en) * 1992-06-25 1996-02-22 F. Hoffmann-La Roche Ag Hydroxamic acid derivatives
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
GB9411088D0 (en) * 1994-06-03 1994-07-27 Hoffmann La Roche Hydroxylamine derivatives
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
US5672598A (en) * 1995-03-21 1997-09-30 The Procter & Gamble Company Lactam-containing hydroxamic acids
US5917090A (en) * 1995-06-30 1999-06-29 British Biotech Pharmaceuticals Ltd. Matrix metalloproteinase inhibitors
DE69716934T2 (de) * 1996-08-28 2003-07-31 The Procter & Gamble Company, Cincinnati 1,3-diheterozyklische metalloprotease inhibitoren
AU731319B2 (en) * 1996-08-28 2001-03-29 Procter & Gamble Company, The Heterocyclic metalloprotease inhibitors
PL331854A1 (en) * 1996-08-28 1999-08-16 Procter & Gamble Phosphinamides as inhibitors of metaloprotease matrix
BR9712085A (pt) 1996-08-28 2000-10-24 Procter & Gamble Inibidores de metaloprotease heterocìclicos
TR199900429T2 (xx) * 1996-08-28 1999-05-21 The Procter & Gamble Company Spirosiklik metaloproteaz inhibit�rleri.
CZ298048B6 (cs) 1996-09-10 2007-06-06 British Biotech Pharmaceuticals Limited Farmaceutický prostredek a deriváty kyseliny hydroxamové
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
WO1999006340A2 (en) 1997-07-31 1999-02-11 The Procter & Gamble Company Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
HUP0202199A2 (en) 1999-03-03 2002-10-28 Procter & Gamble Alkenyl- and alkynyl-containing metalloprotease inhibitors
AU2001271068A1 (en) * 2000-07-18 2002-01-30 Chugai Seiyaku Kabushiki Kaisha Matrix metalloprotease inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2518088B1 (fr) * 1981-12-16 1987-11-27 Roques Bernard Nouveaux derives d'aminoacides, et leur application therapeutique
US4599361A (en) * 1985-09-10 1986-07-08 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors

Also Published As

Publication number Publication date
EP0231081A2 (en) 1987-08-05
ES2053525T3 (es) 1994-08-01
DE3784743T2 (de) 1993-06-24
GB8601368D0 (en) 1986-02-26
EP0231081A3 (en) 1989-11-15
DE3784743D1 (en) 1993-04-22
ATE87005T1 (de) 1993-04-15
JP2532859B2 (ja) 1996-09-11
JPS62228097A (ja) 1987-10-06
EP0231081B1 (en) 1993-03-17

Similar Documents

Publication Publication Date Title
GB8601368D0 (en) Hydroxamic acids
IE901040L (en) N-(3-hydroxy-4-piperidinyl)(dihydro-benzofuran,¹dihydro-2h-benzopyran or dihydrobenzodioxin)carboxamide¹derivatives
EP0151824A3 (en) N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives
PL301581A1 (en) Novel hiv protease inhibitors, method of obtaining such inhibitors and pharmaceutical preparation
PL288201A1 (en) Method of obtaining novel derivatives of amino acide
EP0237051A3 (en) Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same
ES8305695A1 (es) Procedimiento para preparar derivados de amidas.
MY131193A (en) 7-(2-aminoethyl)-benzothiazolones
BR9305164A (pt) Composto, formulação farmacêutica e processo para preparar um composto
EP0193904A3 (en) Amino acid derivatives and processes for preparation thereof
HU9402218D0 (en) Pyridinecarboximidamide compounds, pharmaceutical compositions containing them and process for producing them
AU590172B2 (en) Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
EP0177087A3 (en) 1h-indol-3-yl containing 1,3-dimethyl-1h-purine-2,6-diones
AU3895689A (en) Cyclic sulfur-containing amino acid derivatives
PH21632A (en) Process for preparing n-substituted amido amino acid
HU896173D0 (el)
DE3665593D1 (en) Peptide immunostimulants
ZA9610804B (en) 4-Imidazolidinone compound process for its preparation and the pharmaceutical compositions which contain it
NZ208805A (en) #q#-allenic-substituted amino acids and pharmaceutical compositions